| Primary |
| Diarrhoea |
25.7% |
| Hypertension |
16.3% |
| Medical Diet |
5.8% |
| Diabetes Mellitus |
5.0% |
| Product Used For Unknown Indication |
5.0% |
| Vitamin Supplementation |
5.0% |
| Blood Cholesterol Increased |
4.7% |
| Cardiac Disorder |
4.1% |
| Blood Cholesterol |
3.2% |
| Gastrooesophageal Reflux Disease |
3.2% |
| Osteoporosis |
3.2% |
| Nutritional Support |
2.6% |
| Blood Disorder |
2.3% |
| Diuretic Therapy |
2.3% |
| Short-bowel Syndrome |
2.3% |
| Anxiety |
2.0% |
| Asthma |
2.0% |
| Abnormal Faeces |
1.7% |
| Emphysema |
1.7% |
| Fluid Retention |
1.7% |
|
| Haematochezia |
12.9% |
| Wrong Technique In Drug Usage Process |
11.3% |
| Overdose |
8.1% |
| Weight Decreased |
8.1% |
| Drug Ineffective |
6.5% |
| Tooth Fracture |
6.5% |
| Urinary Retention |
6.5% |
| Dysphagia |
4.8% |
| Dyspnoea |
4.8% |
| Product Quality Issue |
4.8% |
| Diarrhoea |
3.2% |
| Faecaloma |
3.2% |
| Malaise |
3.2% |
| Presyncope |
3.2% |
| Retching |
3.2% |
| Vomiting |
3.2% |
| Abdominal Pain Upper |
1.6% |
| Appetite Disorder |
1.6% |
| Asthma |
1.6% |
| Blood Pressure Increased |
1.6% |
|
| Secondary |
| Diarrhoea |
23.7% |
| Hypertension |
15.3% |
| Medical Diet |
7.4% |
| Blood Cholesterol Increased |
5.1% |
| Cardiac Disorder |
5.1% |
| Pain |
5.1% |
| Diabetes Mellitus |
4.4% |
| Gastrooesophageal Reflux Disease |
4.4% |
| Product Used For Unknown Indication |
4.0% |
| Vitamin Supplementation |
4.0% |
| Osteoporosis |
3.0% |
| Irritable Bowel Syndrome |
2.8% |
| Blood Cholesterol |
2.6% |
| Anticoagulant Therapy |
2.1% |
| Nutritional Support |
2.1% |
| Blood Disorder |
1.9% |
| Diuretic Therapy |
1.9% |
| Short-bowel Syndrome |
1.9% |
| Anxiety |
1.6% |
| Asthma |
1.6% |
|
| Haematochezia |
13.5% |
| Wrong Technique In Drug Usage Process |
9.5% |
| Overdose |
6.8% |
| Weight Decreased |
6.8% |
| Hypoaesthesia |
5.4% |
| Nausea |
5.4% |
| Rash Pruritic |
5.4% |
| Tooth Fracture |
5.4% |
| Urinary Retention |
5.4% |
| Drug Ineffective |
4.1% |
| Dysphagia |
4.1% |
| Dyspnoea |
4.1% |
| International Normalised Ratio Increased |
4.1% |
| Product Quality Issue |
4.1% |
| Diarrhoea |
2.7% |
| Faecaloma |
2.7% |
| Faeces Discoloured |
2.7% |
| Gastric Ulcer |
2.7% |
| Malaise |
2.7% |
| Presyncope |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
59.9% |
| Multiple Myeloma |
5.0% |
| Pain |
4.6% |
| Hypertension |
4.4% |
| Nausea |
3.1% |
| Diarrhoea |
2.9% |
| Non-small Cell Lung Cancer |
2.1% |
| Constipation |
1.9% |
| Crohn's Disease |
1.9% |
| Vomiting |
1.9% |
| Anxiety |
1.5% |
| Colorectal Cancer Metastatic |
1.5% |
| Depression |
1.3% |
| Prostate Cancer |
1.3% |
| Rash |
1.3% |
| Hepatic Neoplasm Malignant |
1.1% |
| Lung Neoplasm Malignant |
1.1% |
| Prophylaxis |
1.1% |
| Antidiarrhoeal Supportive Care |
1.0% |
| Blood Pressure |
1.0% |
|
| Diarrhoea |
15.7% |
| Pneumonia |
11.8% |
| Death |
7.8% |
| Anaemia |
3.9% |
| Arthralgia |
3.9% |
| Cholelithiasis |
3.9% |
| Coronary Artery Disease |
3.9% |
| Dehydration |
3.9% |
| Dry Skin |
3.9% |
| Eye Discharge |
3.9% |
| Fatigue |
3.9% |
| Graft Versus Host Disease |
3.9% |
| Hepatic Enzyme Increased |
3.9% |
| Injection Site Pain |
3.9% |
| Intervertebral Disc Degeneration |
3.9% |
| Large Intestine Perforation |
3.9% |
| Nausea |
3.9% |
| Pulmonary Embolism |
3.9% |
| Vomiting |
3.9% |
| Activities Of Daily Living Impaired |
2.0% |
|
